Safety Study Of Nasal HIV Vaccine Adjuvanted With LTK63

Mise à jour : Il y a 4 ans
Référence : NCT00369031

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to determine whether an HIV vaccine given as three nasal immunisations with a protein from HIV virus mixed with a toxoid adjuvant, followed by two intramuscular immunisations with the same protein mixed with a liquid adjuvant, causes untoward adverse reactions when administered to healthy adult volunteers. An initial evaluation of immune responses to the vaccine will also be undertaken.


Critère d'inclusion

  • HIV Infections

Liens